Hypomethylated DSCR4 is a placenta-derived epigenetic marker for trisomy 21

Prenatal Diagnosis

Volumn 31, Issue 2, 2011, Pages 207-214

  Du, Yingying ^a   Zhang, Jin ^a   Wang, Huijun ^a   Yan, Xiaoling ^b   Yang, Yingjun ^b   Yang, Lu ^a   Luo, Xin ^a   Chen, Yating ^a   Duan, Tao ^b   Ma, Duan ^a  

^a FUDAN UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cell free fetal DNA; DNA methylation; Noninvasive prenatal detection; Trisomy 21

Indexed keywords

ARTICLE; COMBINATION OF METHYLATED DNA PRECIPITATION AND METHYLATION SENSITIVE RESTRICTION ENZYMES ASSAY; COMBINED BISULFITE RESTRICTION ANALYSIS; DNA METHYLATION; DOWN SYNDROME CRITICAL REGION GENE 4; ENZYME ASSAY; EPIGENETICS; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; GENETIC MARKER; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL PLASMA; METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; PLACENTA; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; TRISOMY 21;

BIOLOGICAL MARKERS; DNA METHYLATION; DOWN SYNDROME; EPIGENESIS, GENETIC; FEMALE; HUMANS; MALE; PLACENTA; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, THIRD;

EID: 79251487888     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2684     Document Type: Article

References (34)

1. Bera TK, Zimonjic DB, Popescu NC, et al. 2002. POTE, a highly homologous gene family located on numerous chromosomes and expressed in prostate, ovary, testis, placenta, and prostate cancer. Proc Natl Acad Sci USA 99: 16975-16980.
2. Chan KC, Ding C, Gerovassili A, et al. 2006. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 52: 2211-2218.
3. Chim SS, Jin S, Lee TY, et al. 2008. Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21. Clin Chem 54: 500-511.
4. Chim SS, Tong YK, Chiu RW, et al. 2005. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci USA 102: 14753-14758.
5. Chiu RW, Chim SS, Wong IH, et al. 2007. Hypermethylation of RASSF1A in human and rhesus placentas. Am J Pathol 170: 941-950.
6. Chiu RW, Lau TK, Cheung PT, Gong ZQ, Leung TN, Lo YM. 2002a. Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clin Chem 48: 778-780.
7. Chiu RW, Lau TK, Leung TN, Chow KC, Chui DH, Lo YM. 2002b. Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet 360: 998-1000.
8. Cuckle H. 2001. Time for total shift to first-trimester screening for Down's syndrome. Lancet 358: 1658-1659.
9. Dhallan R, Guo X, Emche S, et al. 2007. A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study. Lancet 369: 474-481.
10. Faas BH, Beuling EA, Christiaens GC, Von Dem Borne AE, Van Der Schoot CE. 1998. Detection of fetal RHD-specific sequences in maternal plasma. Lancet 352: 1196.
11. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. 2008. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA 105: 16266-16271.
12. Go AT, Visser A, Mulders MA, Blankenstein MA, Van Vugt JM, Oudejans CB. 2007. 44 single-nucleotide polymorphisms expressed by placental RNA: assessment for use in noninvasive prenatal diagnosis of trisomy 21. Clin Chem 53: 2223-2224.
13. Gonzalez-Gonzalez MC, Garcia-Hoyos M, Trujillo MJ, et al. 2002. Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat Diagn 22: 946-948.
14. Honda H, Miharu N, Ohashi Y, et al. 2002. Fetal gender determination in early pregnancy through qualitative and quantitative analysis of fetal DNA in maternal serum. Hum Genet 110: 75-79.
15. Leung TN, Zhang J, Lau TK, Chan LY, Lo YM. 2001. Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem 47: 137-139.
16. Leung TN, Zhang J, Lau TK, Hjelm NM, Lo YM. 1998. Maternal plasma fetal DNA as a marker for preterm labour. Lancet 352: 1904-1905.
17. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25: 402-408.
18. Lo YM, Corbetta N, Chamberlain PF, et al. 1997. Presence of fetal DNA in maternal plasma and serum. Lancet 350: 485-487.
19. Lo YM, Hjelm NM, Fidler C, et al. 1998. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 339: 1734-1738.
20. Lo YM, Tsui NB, Chiu RW, et al. 2007. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 13: 218-223.
21. Lui YY, Chik KW, Chiu RW, Ho CY, Lam CW, Lo YM. 2002. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem 48: 421-427.
22. Malone FD, Canick JA, Ball RH, et al. 2005. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 353: 2001-2011.
23. Nakamura A, Hattori M, Sakaki Y. 1997. A novel gene isolated from human placenta located in Down syndrome critical region on chromosome 21. DNA Res 4: 321-324.
24. Old RW, Crea F, Puszyk W, Hulten MA. 2007. Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome. Reprod Biomed Online 15: 227-235.
25. Oudejans CB, Go AT, Visser A, et al. 2003. Detection of chromosome 21-encoded mRNA of placental origin in maternal plasma. Clin Chem 49: 1445-1449.
26. Papageorgiou EA, Fiegler H, Rakyan V, et al. 2009. Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies. Am J Pathol 174: 1609-1618.
27. Saito H, Sekizawa A, Morimoto T, Suzuki M, Yanaihara T. 2000. Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 356: 1170.
28. Sekizawa A, Sugito Y, Iwasaki M, et al. 2001. Cell-free fetal DNA is increased in plasma of women with hyperemesis gravidarum. Clin Chem 47: 2164-2165.
29. Shiraishi M, Sekiguchi A, Oates AJ, Terry MJ, Miyamoto Y, Sekiya T. 2004. Methyl-CpG binding domain column chromatography as a tool for the analysis of genomic DNA methylation. Anal Biochem 329: 1-10.
30. Stemmer C, Beau-Faller M, Pencreac'h E, et al. 2003. Use of magnetic beads for plasma cell-free DNA extraction: toward automation of plasma DNA analysis for molecular diagnostics. Clin Chem 49: 1953-1955.
31. Tong YK, Jin S, Chiu RW, et al. 2010. Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. Clin Chem 56: 90-98.
32. Tsui DW, Chan KC, Chim SS, et al. 2007. Quantitative aberrations of hypermethylated RASSF1A gene sequences in maternal plasma in pre-eclampsia. Prenat Diagn 27: 1212-1218.
33. Xiong Z, Laird PW. 1997. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 25: 2532-2534.
34. Yegnasubramanian S, Lin X, Haffner MC, Demarzo AM, Nelson WG. 2006. Combination of methylated-DNA precipitation and methylation-sensitive restriction enzymes (COMPARE-MS) for the rapid, sensitive and quantitative detection of DNA methylation. Nucleic Acids Res 34: e19.